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Background: The most widespread, efficient prokaryotic protein-producing system is one where the T7 phage
polymerase recognizes the T7 phage promoter (T7 p/p system). Unfortunately, in this system, target protein
expression gradually declines and is often undetectable following 3 to 5 subcultures. Although a number of studies
have attempted to stabilize the expression levels of the T7 p/p system, none has resolved the problem adequately
and thus precludes the use of this system for the production of recombinant proteins on a large scale.
Results: We created an expression cassette enabling stable, high-level expression in the T7p/p system. The cassette
was tested with two different vector backbones and two target proteins. In all experiments, the expression system
using the new cassette exhibited high and stable protein expression levels when compared to the traditional
system.
Conclusions: Herein, we describe a universal expression cassette that enables high-level, stable target protein
expression in T7 RNA polymerase-based expression systems. We also present the successful use of this cassette as a
novel expression platform and demonstrate its ability to overcome the main deficiency of the T7 p/p system. Thus,
we provide a method for using the T7 p/p system on an industrial scale.
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The potential to produce recombinant proteins in pro-
karyotic systems, which are difficult and/or expensive to
enlist from natural sources, was a major breakthrough in
biotechnology [1]. It was enabled by a discovery in the
1980's, in which a system based on RNA polymerases,
dependent upon DNA, was incorporated into host cells
[2]. These cells were transformed with vectors bearing a
recombinant gene under the control of promoters recog-
nized by these polymerases. Currently, one of the most
widely used prokaryotic protein-producing systems uses
the T7 phage polymerase that recognizes the T7 phage
promoter [3]. In many cases, this system has proven ex-
tremely effective and has permitted high levels of target
protein expression to be obtained, up to 50% of the total
cellular protein production [4]. However, the system is* Correspondence: kesikm@iba.waw.pl
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distribution, and reproduction in any mediumnot without its problems, especially a gradual decrease
in the expression levels of the target gene. After several
(3 to 5) subcultures, the induced expression levels may
be comparable to basal expression levels, and often the
host cells do not express detectable levels of the target
protein [5]. This results in a lower target protein yield.
Previously, it was thought that decreased protein expres-
sion was caused by loss of, or mutations in, the plasmid
bearing the target gene. Many attempts have been made
to stabilize the expression levels of the T7 p/p system,
including examination of plasmid stability by lowering
the uninduced T7 polymerase production levels. An-
other approach used freshly transformed bacteria to ob-
tain the target protein [5-9]. However, none of these
approaches have resolved the problem adequately.
The aim of our study was to address the deficiencies
of traditional T7 promoter-based systems and create a
novel system enabling long-term, stable expression of
target proteins in bacteria cell factories.Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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buting factor of decreased expression levels in the T7-
based system was random chromosomal mutations
occurring in the sequence encoding the T7 phage RNA
polymerase. Thus, selection pressure favored cells
whose metabolism was not burdened by the production
of the target protein [5]. In traditional systems, non-
overproducing cells quickly dominate the culture [10].
Our approach aims to overcome the problem of
reduced expression by eliminating non-overproducing
cells from the culture. We achieved this goal by the cre-
ation of a stable expression T7C p/p system in which
the loss of functional polymerase, T7 RNA polymerase
promoter, plasmid and any failure disabling the produc-
tion of the target recombinant protein induces the
death of the host cell. Therefore, we maintain only tar-
get protein-expressing cells in the culture and achieve a
stable high level of recombinant protein expression.
Results and discussions
The novel T7C p/p system created was based on an ex-
pression cassette (ECKm cassette) (Figure 1) controlled by
a T7 promoter introduced into the expression vector. The
gene encoding aminoglycoside-3’-phosphotransferase
(APH) that induces kanamycin resistance, was inserted to
the ECKm cassette as a selection factor. A transcription
terminator for promoters other than the T7 phage pro-
moter was placed ahead of the 5' end of the selection mar-
ker APH gene to preclude the expression of the selection
marker by any polymerase other than the T7 phage poly-
merase. This prevented expression of the selection marker
by non-phage promoters present in the expression vector,
which may be recognized by the host cell polymerases.
Therefore, production of the selection marker was strictly
controlled by the T7 phage promoter recognized by the
T7 phage polymerase. This resulted in the novel cassette
exhibiting the required characteristics.
We tested the function of the expression cassette
when introduced into two plasmid backbones,
pIGDMCT7RS and pT7RS, using two different target
polypeptides, the kE2 protein from the Classical Swine
Fever Virus and the PA-4D protein from Bacillus
anthracis (Figure 2). Both plasmid vectors used con-
tained genes encoding AGA and AGG tRNAs, which
supplement the shortage of these tRNAs that resultsFigure 1 Schematic representation of the expression cassette
with the T7 promoter. The diagram represents a variant of the
cassette. TT–transcription terminator sequence from the tryptophan
operon; S–translation termination codon (TAA).from the codon usage in Escherichia coli. We used two
types of selection markers in our experiments. The Type
I selection marker is functionally independent from the
expression cassette, and is present on the expression
vector and forces the preservation of the vector in the
host cells when they are cultured in the selective
medium. This procedure is standard for cell selection,
and thus we could replicate the behavior of a standard
T7 p/p system in which only cells that do not express
the selection marker are eliminated from the culture.
The Type II selection marker was tightly linked to the
expression of the target protein. This type of marker
could be expressed only when all elements of the T7
phage promoter-based system remained functional. As a
result, from the earliest culture stages, any damage that
impaired a cell's ability to produce the target protein also
caused it to stop producing the selection marker. There-
fore, only those cells expressing the target protein were
able to grow in the culture. The Type II selection marker
is an integral part of the expression cassette.
To confirm that T7 polymerase is required and re-
sponsible for the expression of selection marker from
the cassette we performed experiment A. In this experi-
ment we transformed Bl21(DE3) and DH5α E. coli
strains with plasmids containing the expression cassette.
Bl21(DE3) is a λDE3 lysogen strain of E. coli, which har-
bors a genomic copy of the gene for T7 RNA polymer-
ase under the control of the lac repressor. In this strain,
T7 RNA polymerase is produced after induction with
isopropyl-β-D-galactoside (IPTG).
DH5α, the second strain used in the experiment, has
no T7 bacteriophage polymerase gene in its chromo-
some. Both bacteria strains were transformed with
pGKE2, pGKPA and p7KE2 plasmids. The expression
vectors used in the experiment are listed in Table 1 and
shown in Figure 2. Bacteria transformed with pGKE2
and pGKPA were plated on LB medium supplemented
with Cm or Km while bacteria transformed with p7KE2
were plated on LB supplemented with Amp or Km.
E. coli DH5α transformed with the plasmids were
growing normally when plated on LB supplemented with
Cm or Amp. However, bacteria of this strain did not
grow on LB supplemented with Km. Type I selection
marker independent from T7 polymerase is responsible
for resistance to Cm and Amp antibiotics. On the other
hand, resistance to Km is granted by Type II selection
marker and is dependent on the presence of polymerase
T7. As DH5α does not express the T7 polymerase, there
is also no expression of Type II selection marker.
E. coli Bl21(DE3) transformed with appropriate plas-
mid grew on LB supplemented with Cm, Amp and Km.
In our experiments it was observed, that even without
induction with IPTG the basal expression level of T7






































Figure 2 Expression vector maps. ARG t-RNA−gene encoding AGA and AGG tRNA; CatA1−chloramphenicol resistance gene; Amp−ampicillin
resistance gene; ORI−origin of replication; PA-4D−the fourth domain of the protection antigen of Bacillus anthracis. Target protein; kE2−fragment
of the E2 antigen of CSFV. Target protein; S + TT + Km−expression cassette.
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IPTG induction.
The results from this experiment prove that the cas-
sette exhibits the required characteristics: the bacteria
are resistant to Km only when the T7 polymerase is
produced.
Subsequently, we performed a series of experiments to
characterize the new expression system. Table 2 sum-
marizes the design of experiments described below. The
expression vectors used in the experiments are listed in
Table 1 and shown in Figure 2.
E. coli strain, BL21(DE3), was used for the overproduc-
tion of proteins in all the experiments.
Experiment B examined the difference in the expres-
sion levels of the kE2 protein in E. coli harboring thepGKE2 expression vector between cultures with different
selection markers: chloramphenicol resistance (CmR) as
the Type I marker and kanamycin resistance (KmR) as
the Type II marker. Results of these experiments are
presented in Figure 3B.
Experiment C analyzed the difference in expression
levels of the kE2 protein in E. coli harboring the p7KE2
expression vector between cultures with different selec-
tion markers: ampicillin resistance (AmpR) as the Type I
marker and KmR as the Type II marker. Results of these
experiments are shown in Figure 3C.
Experiment D compared the expression levels of the
target polypeptide obtained in a commonly used system,
T7 p/p, with the expression levels for the novel T7C p/p
system described here. To this end, two vectors were
Table 1 Construction of the expression vectors
Expression vector name Plasmid backbone Expression cassette Sequence encoding target protein
pGKE2 pIGDMCT7RS ECKm kE2 gene of CSFV virus.
pGKPA pIGDMCT7RS ECKm PA-4D of B. anthracis
pGPA pIGDMCT7RS (none) PA-4D of B. anthracis
p7KE2 pT7RS ECKm kE2 gene of CSFV virus.
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an introduced sequence encoding PA-4D (pGPA), and a
modified vector containing the sequence encoding PA-
4D as a part of the expression cassette (pGKPA). We
used two different selection markers: CmR as the Type I
marker and KmR as the Type II marker. Results of these
experiments are presented in Figure 3D.
Target protein expression levels were the same for
both selection marker types between 4 to 6 hours after
induction (Figure 3B,C,D). However, at 6 to 8 hours after
protein expression induction, cultures with the Type I
selection marker demonstrated diminished target protein
expression levels. This phenomenon was observed in all
three experiments (B, C and D). The gradual decrease in
expression levels of the target gene is because of the
Type I selection that forces the cell to retain the expres-
sion vector and protect the expression mechanism of the
selection marker but not the target protein. Because
overexpression of the target protein poses a significant
burden on the host cell metabolism, cells that undergo
mutations that allow the expression of the selection mar-
ker, but not the target protein, are favored, divide faster,
and ultimately overgrow the culture.
In the experimental cultures with the Type II marker,
we observed consistently high expression levels through-
out the course of the experiments. Notably, the observed
protein expression levels for this marker type were equal
to initial protein expression levels observed in experi-
ments using Type I marker. While the expression levels
were stable for Type II marker, they were visibly declin-
ing for Type I marker.
Differences in expression levels between cultures with
the Type I and Type II markers increased with time and
were caused by the Type II marker allowing to surviveTable 2 Experimental design
Experiment Expression vector Markers
Type I Type II
B pGKE2 CmR KmR
C p7KE2 AmpR KmR
D pGKPA CmR KmR
pGPA CmR −only these cells which maintained the expression vector
and had a correctly functioning expression system. This
eliminated non-overproducer cells from the culture.
Our results show that improved stability did not im-
pair the target protein expression levels. In addition the
production level of the Type II selection factor is so low,
that it is not seen on SDS-PAGE (Figure 3). Yet, as our
experiments demonstrate, the expression level of the se-
lection marker was sufficient to allow the host cells to
grow and divide in the selection media. Additionally, our
system exploited the phenomenon of the basal expres-
sion of T7 RNA polymerase, allowing medium contain-
ing the selective antibiotic to be used at all stages of the
culture (even before induction). In traditional T7 p/p
systems, the existence of even basal expression generates
a burden on the host cells metabolism, giving a selective
advantage to non-overproducing cells [11].
The T7C p/p system can also be used to express
proteins toxic to E. coli cells. However, in this case
basal expression is disadvantageous, and specialized com-
mercially available strains expressing T7 lysozyme should
be used [7]. In addition, this case requires the selective
antibiotic to be added to the medium after induction of
T7 RNA polymerase production (data not shown).
The described T7C p/p system allows optimization of
the target protein expression, indicating the possibility
of obtaining high yields of the target protein in large-
scale cultures. High target protein content at the time of
culture harvest facilitates target protein purification.
An additional advantage of T7C system is the reduc-
tion of time-consuming laboratory procedures. Small-
scale test expression is widely used as a predictive tool
to determine which of the clones produces the target
protein [3]. Use of T7C system allows omission of thisType of experiment Antibiotic in
selective medium
Target protein
♦ experiment Km kE2
◊ control Cm
♦ experiment Km kE2
◊ control Amp
♦ experiment Km PA-4D
◊ control Cm
Table 3 Primers used for cassettes and vector
construction












Figure 3 Comparison of the expression levels of target proteins in E. coli with or without the selection of expressing cells. The
SDS-PAGE results in B, C and D show the expression levels of the target protein from experiments B, C and D respectively. The numbers over
each lane indicate how many hours passed between the induction with IPTG and the collection of the sample. ♦–experimental cultures: selection
with kanamycin; ◊–control cultures: medium without kanamycin.
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biotic from the earliest stage (even before induction).
Therefore eliminating non-overproducing cells from the
culture. The gain is especially notable when testing large
numbers of genetic constructs for target protein
expression.
Conclusions
In this study, we present a novel, universal method for
stable, high-level recombinant protein production in bacter-
ial cells. This method increases the efficiency and cost com-
petitiveness of target protein production in bacterial cells.
We demonstrate the applicability of this method for the en-
hancement of the T7 phage RNA polymerase-based expres-
sion system, the most widespread recombinant protein
production system used in laboratories worldwide. We
demonstrated the ability of this system to overcome the
chief deficiency of the T7p/p system – the gradual decline
of target protein production. We tested the method using
two different vector backbones and two different target
proteins. In all experiments, stable, high-level long-term ex-
pression of the target protein was attained.
This expression system can significantly enhance pro-
tein expression for both the laboratory and large-scale




A schematic representation of the expression cassette
with the T7 promoter is shown in Figure 1. Thesequences of the oligonucleotides and primers used for
construction of the cassettes and the expression vectors
are listed in Table 3. All expression vectors used are
listed in Table 1.
Four synthetic oligonucleotides (Tryp1, Tryp2, Tryp3,
and Tryp4) were ligated to form a synthetic DNA frag-
ment encoding the transcription terminator sequence of
the tryptophan operon. A TAA translational stop codon
(designated S), SalI "sticky" end and NotI restriction site
were added to the 5’-end of the fragment. A NotI "sticky"
end was introduced at the 3’-end of the fragment. The
created DNA fragment was designated S +TT.
The DNA fragment containing the region encoding
aminoglycoside-3’-phosphotransferase (APH) (kanamycin
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of the gene was amplified by PCR with SalINotI 5'Kan and
HindIII 3'Kan primers. SalI and NotI restriction sites were
added to the 5’-end. A HindIII restriction site and a TAA
translation termination codon were introduced at the 3’-end
of the amplified fragment. The PCR fragment was digested
with SalI and HindIII.
The digested S +TT DNA fragment and the APH gene
fragment were ligated together to create the ECKm
cassette.
Expression vector construction
To clone the expression cassettes, we used two plasmid
backbones: pIGDMCT7RS and pT7RS [GenBank acces-
sion nos. DQ485721 and AY923866, respectively]. These
vectors carry a T7 phage RNA polymerase promoter, a
sequence encoding the translational stop codon of the
T7 phage and genes encoding AGA and AGG tRNAs,
which supplement the shortage of these tRNAs that
results from the codon usage in E. coli. Both plasmids
carry resistance genes, allowing the selection of bacteria
harboring these plasmids. pIGDMCT7RS carries a chlor-
amphenicol resistance gene, CatA1, and pT7RS carries
an ampicillin resistance gene.
The ECKm cassette was cloned into the pIGDMCT7RS
and pT7RS backbones between the SalI and HindIII
restriction sites, and the resulting plasmids were desig-
nated pGK and p7K, respectively.
For target proteins, two different polypeptides originat-
ing from two organisms were used: a 220 amino acid (aa)
fragment of the E2 (kE2) protein from Classical Swine
Fever Virus (CSFV) and PA-4D (143 aa) of Bacillus
anthracis.
The complete nucleotide sequence of the E2 antigen of
CSFV was used to amplify kE2, a 1023 bp fragment cor-
responding to nt 2428–3087, according to the E2 se-
quence [GenBank accession no. M31768]. The sequence
was amplified by PCR with NdeI 5'E2 and XhoI 3'E2 pri-
mers. An NdeI site and GCA codon were added, and the
guanine was altered to a thymine at the 5’-end. A HindIII
restriction site and TAA translation stop codon were
introduced at the 3’-end of the amplified fragment. The
kE2 fragment was digested with NdeI and HindIII restric-
tion enzymes and cloned into pGK using the same
restriction sites. The resulting vector was designated
pGKE2 (Figure 2A).
To create p7KE2 (Figure 2B), a segment consisting of
the sequences encoding kE2, the transcription termin-
ator sequence from the tryptophan operon, and APH
was removed from the pGKE2 vector using NdeI and
HindIII restriction enzymes and shuttled into the pT7RS
backbone at the NdeI-HindIII restriction sites.
The complete nucleotide sequence of the protection
antigen (PA) of Bacillus anthracis was used to amplifythe fourth domain (PA-4D) of PA, a 429 bp fragment,
according to the PA sequence [GenBank accession no.
AF065404]. Two amplifications were conducted: the first
one with NdeI 5'PA4D and SalI 3'PA4D primers; the sec-
ond with NdeI 5'PA4D and HindIII 3'PA4D primers. Be-
cause of the first amplification, an NdeI restriction site
was added at the 5’-end, and a SalI restriction site was
added at the 3’-end of the amplified fragment. In the
second amplification, an NdeI restriction site was added
at the 5’-end, and a HindIII restriction site was added at
the 3’-end of the amplified fragment. The amplified
fragment was then digested with NdeI and SalI and
cloned into the pGK vector at the corresponding re-
striction sites. The final vector was designated pGKPA
(Figure 2C). The fragment digested with NdeI and
HindIII was cloned into the NdeI/HindIII restriction
sites of pIGDMCT7RS. The final vector was designated
pGPA (Figure 2D).
All described vectors are summarized in Table 1.
Standard protocols were used for PCR, restriction
digests, ligations, and transformations as previously
described [12,13].Expression of selection markers
In the experiments were used competent DH5α and
Bl21(DE3) E. coli strains purchased form Stratagene.
Bacteria were transformed with plasmids pGKPA,
pGKE2, p7KE2. All these plasmids contain ECKm ex-
pression cassette. After the transformation bacteria were
plated in duplicate onto LB medium supplemented with
appropriate antibiotic: ampicillin-(100 mg/l), chloram-
phenicol-(18 mg/l), kanamycin-(25 mg/l).Expression of the target protein using expression vectors
with the ECKm cassette
The Escherichia coli BL21(DE3) strain was used for over-
production of recombinant proteins in all experiments.
The bacteria strain was obtained from Stratagene. E. coli
bacteria harboring the appropriate recombinant plasmid
were grown in 3 ml of Luria Bertani medium (10 g/L
tryptone, 10 g/L NaCl, and 5g/L yeast extract) at 37°C
for 3 hours. The cultures were then diluted with fresh
medium (1:100) and shaken at 37°C until the A600
reached 0.4–0.7. Subsequently, the target polypeptide ex-
pression was induced by the addition of IPTG (0.1 mM
final concentration), and the shaking was continued for
12 to 20 hours. Media used in the experiments con-
tained the appropriate antibiotic: kanamycin (25 mg/l),
chloramphenicol (18 mg/l), or ampicillin (100 mg/l).
Samples for A600 measurements and electrophoretic
separation on polyacrylamide gels (SDS-PAGE) were col-
lected every 2 hours after induction.
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The presence and quantity of the target polypeptide was
determined by separation of the bacterial lysate on a
15% polyacrylamide gel (SDS-PAGE), carried out as
described by Laemmli [14]. The separated proteins were
visualized by staining with Coomassie Brilliant Blue G.
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